Asif M, Alvi IA, Rehman SU (2018) Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect drug Resist. 1249–1260
Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A (2021) Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens 10(3):373
Article CAS PubMed PubMed Central Google Scholar
Mozafari H, Mirkalantari S, Sadeghi Kalani B, Amirmozafari N (2021) Prevalence determination of virulence related and biofilm formation genes in Acinetobacter baumannii isolates from clinical respiratory samples in Imam Khomeini Hospital, Tehran, Iran in 2018. Iran J Med Microbiol 15(3):266–280
Pakzad I, Yarkarami F, Kalani BS, Shafieian M, Hematian A (2024) Inhibitory effects of carvacrol on biofilm formation in colistin heteroresistant Acinetobacter baumannii clinical isolates. Curr Drug Discov Technol 21(1):119–124
Khoshnood S, Eslami G, Hashemi A, Bahramian A, Heidary M, Yousefi N et al (2017) Distribution of Aminoglycoside resistance genes among Acinetobacter baumannii strains isolated from burn patients in Tehran. Iran 5(3):e57263
Maleki A, Kaviar VH, Koupaei M, Haddadi MH, Kalani BS, Valadbeigi H et al (2022) Molecular typing and antibiotic resistance patterns among clinical isolates of Acinetobacter baumannii recovered from burn patients in Tehran, Iran. Front Microbiol 13:994303
Article PubMed PubMed Central Google Scholar
Karakonstantis S, Saridakis I (2020) Colistin heteroresistance in Acinetobacter spp.: systematic review and meta-analysis of the prevalence and discussion of the mechanisms and potential therapeutic implications. Int J Antimicrob Agents 56(2):106065
Article CAS PubMed Google Scholar
Ezadi F, Jamali A, Heidari A, Javid N, Ardebili A (2020) Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran. J Global Antimicrob Resist 21:380–385
Hematian A, Goudarzi H, Ghalavand Z, Goudarzi M, Shafieian M, Hashemi A et al (2021) The relationship between phoH and colistin-heteroresistant in clinical isolates of Acinetobacter baumannii. Gene Rep 25:101356
Kon H, Hameir A, Temkin E, Keren-Paz A, Schwartz D, Schechner V et al (2021) Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates. Microorganisms 10(1):58
Article PubMed PubMed Central Google Scholar
Karakonstantis S, Rousaki M, Kritsotakis EI, Cefiderocol (2022) Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance. Antibiotics 11(6):723
Article CAS PubMed PubMed Central Google Scholar
Dehbanipour R, Maleki VTZ, Ghalavand Z (2025) Colistin heteroresistance, mechanisms, diagnostic methods, and therapeutic options: A review. Germs 15(2):166
Article PubMed PubMed Central Google Scholar
Zulfiqar A, Hanif F, Irfan R, Qasim A, Usman J (2025) Incidence of colistin heteroresistance among carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Pakistan. Eur J Clin Microbiol Infect Dis 44(1):151–158
Article CAS PubMed Google Scholar
Gerson S, Betts JW, Lucaßen K, Nodari CS, Wille J, Josten M et al (2019) Investigation of novel pmrB and eptA mutations in isogenic Acinetobacter baumannii isolates associated with colistin resistance and increased virulence in vivo. Antimicrob Agents Chemother 63(3):e01586–e01518
Article CAS PubMed PubMed Central Google Scholar
Andersson DI, Nicoloff H, Hjort K (2019) Mechanisms and clinical relevance of bacterial heteroresistance. Nat Rev Microbiol 17(8):479–496
Article CAS PubMed Google Scholar
Charretier Y, Diene SM, Baud D, Chatellier S, Santiago-Allexant E, van Belkum A et al (2018) Colistin heteroresistance and involvement of the PmrAB regulatory system in Acinetobacter baumannii. Antimicrob Agents Chemother 62(9):e00788–e00718
Article CAS PubMed PubMed Central Google Scholar
Hematian A, Karami-Zarandi M, Rahdar HA, Heidari H, Kazemian H (2025) Investigation of colistin heteroresistance in multidrug-resistant Acinetobacter baumannii clinical isolates. New Microbes and New Infections 101633
Karakonstantis S (2020) A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline in Acinetobacter baumannii. J Chemother 33(1):1–11
Ouyang Z, He W, Wu D, An H, Duan L, Jiao M et al (2025) Cryo-EM structure and complementary drug efflux activity of the Acinetobacter baumannii multidrug efflux pump AdeG. Structure 33(3):539–551 e4
Article CAS PubMed Google Scholar
Wu H-J, Xiao Z-G, Lv X-J, Huang H-T, Liao C, Hui C-Y et al (2023) Drug–resistant Acinetobacter baumannii: From molecular mechanisms to potential therapeutics. Experimental therapeutic Med 25(5):209
Xu C, Bilya S, Xu W (2019) adeABC efflux gene in Acinetobacter baumannii. New microbes and new infections 30:100549
Khoshnood S, Sadeghifard N, Mahdian N, Heidary M, Mahdian S, Mohammadi M et al (2023) Antimicrobial resistance and biofilm formation capacity among Acinetobacter baumannii strains isolated from patients with burns and ventilator-associated pneumonia. J Clin Lab Anal 37(1):e24814
Article CAS PubMed Google Scholar
Xie L, Li J, Peng Q, Liu X, Lin F, Dai X et al (2025) Contribution of RND superfamily multidrug efflux pumps AdeABC, AdeFGH, and AdeIJK to antimicrobial resistance and virulence factors in multidrug-resistant Acinetobacter baumannii AYE. Antimicrob Agents Chemother :e01858–e01824
Kwon HI, Kim S, Oh MH, Shin M, Lee JC (2019) Distinct role of outer membrane protein A in the intrinsic resistance of Acinetobacter baumannii and Acinetobacter nosocomialis. Infect Genet Evol 67:33–37
Article CAS PubMed Google Scholar
Zhu LJ, Chen XY, Hou PF (2019) Mutation of CarO participates in drug resistance in imipenem-resistant Acinetobacter baumannii. J Clin Lab Anal 33(8):e22976
Article CAS PubMed PubMed Central Google Scholar
Sehree MM, Abdullah HN, Jasim AM (2021) Isolation and evaluation of clinically important Acinetobacter baumannii from intensive care unit samples. J Techniques 3(3):83–90
Abozahra R, Abdelhamid SM, Elsheredy AG, Abdulwahab KE, Baraka K (2021) Genotyping and molecular characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from intensive care unit patients
Ghasemian S, Karami-Zarandi M, Heidari H, Khoshnood S, Kouhsari E, Ghafourian S et al (2023) Molecular characterizations of antibiotic resistance, biofilm formation, and virulence determinants of Pseudomonas aeruginosa isolated from burn wound infection. J Clin Lab Anal 37(4):e24850
Article CAS PubMed PubMed Central Google Scholar
CLSI K. Performance Standards for Antimicrobial Susceptibility Testing (2018) CLSI Supplement M100, 28th Edn Wayne. Clinical and Laboratory Standards Institute[Google Scholar], PA
Sherman EX, Wozniak JE, Weiss DS (2019) Methods to evaluate colistin heteroresistance in Acinetobacter baumannii. Acinetobacter baumannii: Methods and Protocols. Springer, pp 39–50
Narimisa N, Amraei F, Kalani BS, Mohammadzadeh R, Jazi FM (2020) Effects of sub-inhibitory concentrations of antibiotics and oxidative stress on the expression of type II toxin-antitoxin system genes in Klebsiella pneumoniae. J global Antimicrob Resist 21:51–56
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2 – ∆∆CT method. Methods 25(4):402–408
Article CAS PubMed Google Scholar
Sarshar M, Behzadi P, Scribano D, Palamara AT, Ambrosi C (2021) Acinetobacter baumannii: an ancient commensal with weapons of a pathogen. Pathogens 10(4):387
Article CAS PubMed PubMed Central Google Scholar
Aarjouni Y, Absa Y, Sayouti C, Dafali L, Bentalha A, Kettani SE (2025) Intracardiac thrombus discovered incidentally during respiratory distress in an 18-month-old infant: case report. Pan Afr Med J 50:24
Article PubMed PubMed Central Google Scholar
De Oliveira DM, Forde BM, Kidd TJ, Harris PN, Schembri MA, Beatson SA et al (2020) Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev 33(3):e00181–e00119
Article PubMed PubMed Central Google Scholar
Denissen J, Reyneke B, Waso-Reyneke M, Havenga B, Barnard T, Khan S et al (2022) Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community-acquired infection and risk to human health. Int J Hyg Environ Health 244:114006
Article CAS PubMed Google Scholar
Narimisa N, Amraei F, Kalani BS, Azarnezhad A, Jazi FM (2020) Biofilm establishment, biofilm persister cell formation, and relative gene expression analysis of type II toxin-antitoxin system in Klebsiella pneumoniae. Gene Rep 21:100846
Comments (0)